Approche intégrée des effets de la vitamine D dans la pathogénie de la prééclampsie

Auteurs

  • Richard Kabuyanga Kabuseba Département de Gynécologie-Obstétrique, Université de Goma, RDC
  • Pierrot Lundimu Tugirimana Département de Laboratoire et Sciences de base, Université de Goma, RDC
  • Jean Pierre Elongi Moyene Département de Gynécologie-Obstétrique, Hôpital Général Provincial de Référence de Kinshasa, RDC
  • Xavier Kinenkinda Kalume Département de Gynécologie-Obstétrique, Université de Lubumbashi. RDC
  • Jean-Baptiste Kakoma Sakatolo Zambeze Département de Gynécologie-Obstétrique et École de Santé Publique de Lubumbashi, Université de Lubumbashi. RDC

Mots-clés :

Interleukin, Calcitriol, pathogénie, vitamine D, prééclampsie

Résumé

La prééclampsie est une pathologie d’étiologie moins bien connue associée à une morbi-mortalité materno-foetale importante. La découverte des détails sur sa physiopathologie la dégarnit de sa dénomination séculaire de « maladie des hypothèses ». Plusieurs tentatives de prise en charge sont en perpétuelle validation. Le déficit en vitamine D est associé à un risque important de prééclampsie. Les relations entre les effets de la vitamine D et le processus pathogénique est un domaine qui mérite d’être rappelé en vue d’identifier des bénéfices à exploiter par le clinicien pour renforcer les investigations orientées vers une prise en charge efficiente.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Références

Haroon M, Regan MJ. Vitamin D deficiency: the time to ignore it has passed. International journal of rheumatic diseases. Oct 2010;13(4):318-323. Google Scholar

Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP et al. WHO Multicountry Survey on Maternal and Newborn Health Research Network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG: An International Journal of Obstetrics & Gynaecology. Mar 2014;121:14–24

Jeyabalan A. Epidemiology of preeclampsia: Impact of obesity. Nutrition reviews. 1 Oct 2013;71(suppl_1):S18-25.

American College of Obstetricians and Gynecologists. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstetrics and Gynecology. Jun 2020;135(6):e237-e260.

Lisonkova S, Sabr Y, Mayer C, Young C, Skoll A, Joseph KS. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstetrics & Gynecology. 1 Oct 2014;124(4):771-81.

Powles K, Gandhi S. Postpartum hypertension. CMAJ :Canadian Medical Association journal = journal de l'Association medicale canadienne. 10 Jul 2017;189(27):E913-E913.

Benachi A, Cordier AG, Courbebaisse M, Souberbielle JC. Vitamine D, obstétrique et prééclampsie. La Lettre du Gynécologue. octobre 2012;375:25-27.

Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews. 2007(Issue 2). Art. No.: CD006490.

Hofmeyr G, Manyame S, Medley N, Williams MJ. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy. Cochrane Database of Systematic Reviews. 2019;(Issue 9). Art. No. CD011192.

Lapébie FX, Bezanahary H, Lacroix P, Martin S, Vincelot A, Aubard Y et al. Complications du traitement par aspirine et/ou héparine de bas poids moléculaire au cours de la grossesse: étude rétrospective sur 160 cas. La Revue de Médecine Interne. 1 Dec 2014;35:A62.

mondiale de la Santé O. Recommandation de l’OMS pour la prévention et le traitement de la prééclampsie et de l’éclampsie. 2014.

Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. Bmj. 19 Apr 2016;353:i1753.

Boyd HA, Tahir H, Wohlfahrt J & Melbye M. Associations of Personal and Family Preeclampsia History With the Risk of Early-, Intermediate- and Late-Onset Preeclampsia. Am. J. Epidemiol. 2013;178:1611–1619.

Yanit KE, Snowden JM, Cheng YW, Caughey AB. The impact of chronic hypertension and pregestational diabetes on pregnancy outcomes. American journal of obstetrics and gynecology. 1 Oct 2012;207(4):333-e1.

Heilmann L, Schorsch M, Hahn T, Fareed J. Antiphospholipid syndrome and pre-eclampsia. Semin. Thromb. Hemost. 2011; 37:141–145.

Cruickshank JK, Beevers DG. Epidemiology of hypertension: blood pressure in blacks and whites. Clinical Science. Jan 1982;62(1):1–6.

López-Jaramillo P, Herrera JA, Arenas-Mantilla M, Jáuregui IE, Mendoza MA. Subclinical infection as a cause of inflammation in preeclampsia. American journal of therapeutics. 1 Jul 2008;15(4):373–376.LWW

Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J et al. Paternal and maternal components of the predisposition to preeclampsia. 22 Mar 2001;344(12):867-872.

Skjærven R, Vatten LJ, Wilcox AJ, Rønning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ. 13 Oct 2005;331(7521):877.

Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E et al. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ. 1998;316:1343–1347.

Naimy Z, Grytten J, Monkerud L, Eskild A. The prevalence of pre-eclampsia in migrant relative to native Norwegian women: a population-based study. BJOG Int. J. Obstet. Gynaecol. Mai 2015;122(6):859-865.

Caughey AB, Stotland NE, Washington AE, Escobar GJ. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstetrics & Gynecology. 1 Jul 2005;106(1):156–161.

Hiby SE, Walker JJ, O'shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. Journal of Experimental Medicine. 2004;200:957.

Dekker G, Robillard P-Y. Pre-eclampsia: Is the immune maladaptation hypothesis still standing? Journal of. Reproductive Immunology. 2007.

Ikedife D. Eclampsia in multipara. British Medical Journal. 5 Apr 1980;280(6219):985–986.

Kyrou D, Kolibianakis EM, Devroey P, Fatemi HM. Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? Fertil. Steril. 2010;93(4):1124–1127.

Kho EM, McCowan LM, North RA, Roberts CT, Chan E, Black MA et al. Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. Journal of reproductive immunology. 1 Oct 2009;82(1):66–73.

Einarsson JI, Sangi-Haghpeykar H, Gardner MO. Sperm exposure and development of preeclampsia. American journal of obstetrics and gynecology.1 May 2003;188(5):1241–1243.

Verwoerd GR, Hall DR, Grové D, Maritz JS, Odendaal HJ. Primipaternity and duration of exposure to sperm antigens as risk factors for pre-eclampsia. Int J Gynaecol Obstet. 2002;78(2):121–126.

Koelman CA, Coumans AB, Nijman HW, Doxiadis II, Dekker GA, Claas FH. Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid? J. Reprod. Immunol. 2000;46(2):155–166.

Cerón-Mireles P, Harlow SD, Sánchez-Carrillo CI, Núñez RM. Risk factors for pre-eclampsia/eclampsia among working women in Mexico City. Paediatr Perinat Epidemiol. 2001;15(1):40–46.

Funai EF, Paltiel OB, Malaspina D, Friedlander Y, Deutsch L, Harlap S. Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem perinatal study. Paediatric and perinatal epidemiology. Jan 2005;19(1):59–68.

Keyes LE, Armaza JF, Niermeyer S, Vargas E, Young DA, Moore LG. Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatr. Res. 2003;54:20–25.

Palmer SK, Moore LG, Young D, Cregger B, Berman JC, Zamudio S. Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am. J. Obstet. Gynecol. 1999;180:1161–1168.

Conde-Agudelo A, Belizán JM Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG: An International Journal of Obstetrics & Gynaecology. Jan 2000;107(1):75–83.

Merviel P, Touzart L, Deslandes V, Delmas M, Coicaud M, Gondry J. Risk Factors of Preeclampsia in Single Pregnancy. Journal de Gynécologie Obstétrique et Biologie de la Reproduction. 23 May 2008;37:477-482.

Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. New England Journal of Medicine. 3 Jan 2002;346(1):33–38.

Thomopoulos C, Tsioufis C, Michalopoulou H, Makris T, Papademetriou V, Stefanadis C. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. Journal of human hypertension. Mar 2013;27(3):148–157.

Worley KC, Hnat MD, Cunningham FG. Advanced extrauterine pregnancy: diagnostic and therapeutic challenges. American journal of obstetrics and gynecology. 1 Mar 2008;198(3):297-e1.

Souberbielle JC, Cormier C, Cavalier E, Breuil V, Debiais F, Fardellone P et al. Vitamin D supplementation in France in patients with or at risk for osteoporosis: recent data and new practices. Joint bone spine. 2020;87(1):25-29.

De jaeger C, Cherin P. Vitamine D: effets sur la santé. Recommandations de bon usage. Médecine et Longévité. 2010;2(4):182-199.

Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. InMayo clinic proceedings. 1 Jul 2013;88(7):720–755.

Vyas N, Kurian SJ, Bagchi D, Manu MK, Saravu K, Unnikrishnan MK, Mukhopadhyay C, Rao M , Miraj SS. Vitamin D in prevention and treatment of COVID-19: current perspective and future prospects. Journal of the American College of Nutrition.3 Oct 2021;40(7):1-14.

Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Archives of Internal Medicine. 10 sept 2007;167(16):1730–1737.

Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Reviews in Endocrine and Metabolic Disorders. Jun 2017;18(2):153–165.

Sharma S, Kumar A, Prasad S, Sharma S. Current scenario of vitamin D status during pregnancy in north Indian population. The Journal of Obstetrics and Gynecology of India. 1 Apr 2016;66(2):93-100.

Ponsonby AL, Lucas RM, Lewis S, Halliday J. Vitamin D status during pregnancy and aspects of offspring health. Nutrients. Mar 2010;2(3):389-407.

Holick MF. Resurrection of vitamin D deficiency and rickets. The Journal of clinical investigation. 1 Aug 2006;116(8):2062-72.

Holick MF. Vitamin D deficiency entire monograph. BMJ point of care. 2011:1-19.

Landrier, JF. Vitamine D : sources, métabolisme et mécanismes d’action. Cahiers de Nutrition et de Diététique. 1 Dec 2014;49(6):245-251.

Guilland JC. La vitamine D (Coll. Professions santé). s.l. : Lavoisier, 2015.

Souberbielle JC. Actualités sur la vitamine D. OCL. 1er mai 2014;21(3):D304.

Souberbielle J-C, Maruani G, Courbebaisse M. Vitamine D : Métabolisme et évaluation des réserves. Presse Med.1 Oct 2013;42(10):1343-1350.

Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocrine reviews. 1 Feb 2013;34(1):33-83.

Gondolf., Clémentine. Mise au point et validation d’une méthode de dosage par HPLC-MS/MS de métabolites hydroxylés de la vitamine D. Sciences pharmaceutiques. 2019.

Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: a D-lightful story. Journal of Bone and Mineral Research. 2007;22(S2):V28-V33.

Esterle L. La vitamine D: nouvelles données. Centre de Recherche et d' Information Nutritionnelles. 2010;117:1-6.

Norman AW. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr. Jun 1998;67(6):1108-10.

Guasch A, Bulló M, Rabassa A, Bonada A, Del Castillo D, Sabench F et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovascular diabetology. Dec 2012;11(1):1-11.

Wang TJ, Zhang F, Richards JB, Kestenbaum B, Van Meurs JB, Berry D et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. The Lancet.17 Jul 2010;376(9736):180-188.

Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Leong A et al. Vitamin D and risk of multiple sclerosis: a Mendelian randomization study. PLoS medicine. 25 Aug 2015;12(8):e1001866.

HAS. Utilité clinique du dosage de la vitamine D< http://www.has-sante.fr/portail/jcms/c_1356838/fr/utilite-clinique-du-dosagede- la-vitamine-d-rapport-d-evaluation?xtmc=&xtcr=2 >. www.has-sante.fr. [En ligne] HAS, 2013. [Citation : 13 août 2021.]

Benhamou C-L, Souberbielle J-C, Cortet B, Fardellone P, Gauvain J-B, et al. La vitamine D chez l'adulte : recommandations du GRIO(Groupe de Recherche et d'Information sur les Ostéoporoses). Presse Med . 2011, 40(7/8), pp. 673-82.

Phinney KW, Bedner M, Tai SS, Vamathevan V V, Lane C, Sharpless KE et al. Development and Certification of a Standard Reference Material for Vitamin D Metabolites in Human Serum. Anal chem. . 2013;84 (2):956-962.

Ding S, Schoenmakers I, Jones K, Koulman A, Prentice A, Volmer DA. Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS. Analytical and bioanalytical chemistry. sept 2010;398(2):779-89.

Bertherat J. Biochimie des hormones et leurs mécanismes d’action. D-Récepteurs nucléaires. EMC-Endocrinologie. 2004;1:133-137.

Avila E, Díaz L, Barrera D, Halhali A, Méndez I, González L et al. Regulation of Vitamin D hydroxylases gene expression by 1, 25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts. The Journal of steroid biochemistry and molecular biology. 2007;103(1):90-96.

Shin JS, Choi MY, Longtine MS, Nelson DM. Vitamin D effects on pregnancy and the placenta. Placenta. 1 Dec 2010;31(12):1027-1034.

Murthi P, Yong HEJ, Ngyuen TPH, Ellery S,Singh H, Rahman R et al. Role of the Placental Vitamin D Receptor in Modulating Feto-Placental Growth in Fetal Growth Restriction and Preeclampsia-Affected Pregnancies. Front. Physiol. 2016;7:43.

Ditisheim A, Sibai B, Tatevian N. Placental Findings in Postpartum Preeclampsia: A Comparative Retrospective Study. American journal of perinatology. 2020;37(12):1217-1222.

Nema J, Sundrani D, Joshi S. Role of vitamin D in influencing angiogenesis in preeclampsia. Hypertension in Pregnancy. 2 Oct 2019;38(4):201-7.

Palei AC, Spradley FT, Warrington JP, George EM, Granger JP. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol (Oxf). 2013;208(3):224-233.

Karumanchi SA, MD KH, MD PA. Preeclampsia: Pathogenesis. GOMA, RDC : s.n., 16 Oct 2020. Preeclampsia: Pathogenesis. UpTuDate: kabuyanga kabuseba, MD [Consulté le 16 Oct 2021].

Tsatsaris V, Fournier T, Winer N. Physiopathologie de la pré-éclampsie. Annales Françaises d'Anesthésie et de Réanimation. 1 Mar 2010;29(3):e13-e18.

Weiss G, Goldsmith LT, Taylor RN, Bellet D,Taylor HS. Inflammation in reproductive disorders. Reproductive sciences. 2009;16(2):216-229.

Barrera D, Avila E, Hernández G, Méndez I, González L, Halhali A et al. Calcitriol affects hCG gene transcription in cultured human syncytiotrophoblasts. Reproductive Biology and Endocrinology. Dec 2008;6(1):1-8.

Grundmann M, Haidar M, Placzko S, Niendorf R, Darashchonak N, Hubel CA et al. Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am J Physiol Cell Physiol. 2012;303:C954-62.

Cardus A, Panizo S, Encinas M et al. 1,25- dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis. 2009;204(1):85–89.

Song J, Li Y, An R. Vitamin D restores angiogenic balance and decreases tumor necrosis factor-α in a rat model of pre-eclampsia. J Obstet Gynaecol Res. 2017;43(1):42–80. Brodowski L, Schröder-Heurich B, Hubel CA, Vu TH, von Kaisenberg CS, von Versen-Höynck F. The role of vitamin D in cell-cell interaction of fetal endothelial progenitor cells and umbilical cord endothelial cells in a preeclampsia-like model. American Journal of Physiology-Cell Physiology. 1 Aug 2019;317(2):C348-C357.

Hod T, Cerdeira AS, Karumanchi SA. Molecular Mechanisms of Preeclampsia. Cold Spring Harbor perspectives in medicine. 1 Oct 2015;5(10):a023473.

Nandi AA, Wadhwani NS, Joshi SR. Altered metabolic homeostasis between vitamin D and long chain polyunsaturated fatty acids in preeclampsia. Med Hypotheses. 1 Mar 2017;100:31–36.

Kemse NG, Kale AA, Joshi SR. A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension. PLoS One. 18 Nov 2014;9(11):e111902.

Kulkarni A, Mehendale S, Pisal H, Kilari A, Dangat K, Salunkhe S et al. Association of omega-3 fatty acids and homocysteine concentrations in pre-eclampsia. Clinical Nutrtion. 2011;30(1):60–64.

Zabul P, Wozniak M, Slominski AT, Preis K, Gorska M, Korozan M et al. A proposed molecular mechanism of high-dose vitamin D3 supplementation in prevention and treatment of preeclampsia. International journal of molecular sciences. 2015;16(6):13043–13064.

Xu J, Jia X, Gu Y, Lewis DF, Gu X, Wang Y. Vitamin D reduces oxidative stress-induced procaspase-3/ROCK1 activation and MP release by placental trophoblasts. The Journal of Clinical Endocrinology & Metabolism. 1 Jun 2017;102(6):2100–2110.

Qipshidze N, Metreveli N, Mishra PK, Lominadze D, Tyagi SC. Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis. International journal of biological sciences. 2012;8(4):430–441.

King AL, Polhemus DJ, Bhushan S, Otsuka H, Kondo K, Nicholson CK et al. Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent. Proc Natl Acad Sci U S A. 2014;111(8):3182–3187.

Cindrova-Davies T. The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia. Front Pharmacol. 2014;5:119.

Holwerda KM, Burke SD, Faas MM, Zsengeller Z, Stillman IE, Kang PM et al. Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. Journal of the American Society of Nephrology. 2014;25(4):717–725.

Wiliński B, Wiliński J, Somogyi E, Piotrowska J, Opoka W. Vitamin D3 (cholecalciferol) boosts hydrogen sulfide tissue concentrations in heart and other mouse organs. Folia Biologica (Kraków). 30 Jul 2012;60(3-4):243–7.

Andrukhova O, Slavic S, Zeitz U, Riesen SC, Heppelmann MS, Ambrisko TD et al. Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Molecular Endocrinology. 1 Jan 2014;28(1):53–64.

Kriebitzsch C, Verlinden L, Eelen G, van Schoor NM, Swart K, Lips P et al. 1,25- dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase. Journal of Bone and Mineral Research. Dec 2011;26(12):2991–3000.

Colotta F, Jansson B, Bonelli F. Modulation of inflammatory and immune responses by vitamin D. J Auto-immun. 1 Déc 2017;85:78-97.

Ertek S, Akgül E, Cicero AF, Kütük U, Demirtaş S, Cehreli S, Erdoğan G. 25-Hydroxy vitamin D levels and endothelial vasodilator function in normotensive women. Arch. Med. Sci. AMS. 29 Feb 2012;8(1):47–52.

Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet. Med. J. Br. Diabet. Assoc. 2008;25:320–325.

Wong MS, Leisegang MS, Kruse C, Vogel J, Schürmann C, Dehne N et al. Vitamin D promotes vascular regeneration. Circulation. 16 Sep 2014;130(12):976–986.

Karar J, Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Frontiers in molecular neuroscience. 2 Dec . 2011;4:51.

Cudmore MJ, Ahmad S, Sissaoui S, Ramma W, Ma B, Fujisawa T et al. Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1. European heart journal. 1 May 2012;33(9):1150–1158.

Vaidya A, Sun B, Larson C, Forman JP, Williams JS. Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. The Journal of Clinical Endocrinology & Metabolism. 1 Jul 2012;97(7):2456–2465.

Isenovic ER, Meng Y, Divald A, Milivojevic N, Sowers JR. Role of phosphatidylinositol 3-kinase/Akt pathway in angiotensin II and insulin-like growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells. Endocrine.Dec 2002;19(3):287–292.

Raghupathy Raj. Cytokines as Key Players in the Pathophysiology of Preeclampsia. Med Princ Pract. 2013;22(1):8-19.

Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertension. An International Journal of Women's Cardiovascular Health. 1 Apr 2012;2(2):72-83.

Huppertz B, Kingdom JC. Apoptosis in the trophoblast – role of apoptosis in placental morphogenesis. J Soc Gynecol Invest. 2004;11(6):353–362.

Austgulen R, Lien E, Vince G, Redman CW. Increased maternal plasma levels of soluble adhesion molecules ICAM-1, VCAM-1, E-selectin in preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology. 1 Jan 1997;71(1):53–58.

Hintzpeter B, Mensink GBM, Thierfelder W, Müller MJ, Scheidt-Nave C. Vitamin D status and health correlates among German adults. European journal of clinical nutrition. Sep 2008;62(9):1079-1089.

Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 1 May 2010;55(5):1283-1288.

Ajabshir S, Asif A, Nayer A. The effects of vitamin D on the renin-angiotensin system. Journal of nephropathology. 2014;3(2):41.

Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE et al. 1, 25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin ge. Journal of Biological Chemistry. 12 Oct 2007; 282(41):29821-29830.

Pérez-Gómez MV, Ortiz-Arduán A, Lorenzo-Sellares V. Vitamin D and proteinuria: a critical review of molecular bases and clinical experience. Nefrología (English Edition). 1 Sep 2013;33(5):716-726.

Téléchargements

Publiée

04/25/2022

Comment citer

Kabuyanga Kabuseba, R. ., Lundimu Tugirimana, P. ., Elongi Moyene, J. P. ., Kinenkinda Kalume, X. ., & Kakoma Sakatolo Zambeze, J.-B. . (2022). Approche intégrée des effets de la vitamine D dans la pathogénie de la prééclampsie. Revue Africaine De Médecine Et De Santé Publique, 5(1), 15–35. Consulté à l’adresse http://rams-journal.com/index.php/RAMS/article/view/54

Numéro

Rubrique

Article original